Journal
JOURNAL OF VIROLOGY
Volume 88, Issue 12, Pages 6650-6659Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.03138-13
Keywords
-
Categories
Funding
- 973 Project [2011CB504903]
- National Science Foundation for Outstanding Young Scientists [81225014]
- National Natural Science Foundation of China [31270200]
- Program for Changjiang Scholars and Innovative Research Team in University [IRT13007]
- National Institute of Allergy and Infectious Diseases of the United States [AI092230]
Ask authors/readers for more resources
Human enterovirus 68 (EV68) is a member of the EV-D species, which belongs to the EV genus of the Picornaviridae family. Over the past several years, there have been increasingly documented outbreaks of respiratory disease associated with EV68. As a globally emerging pathogen, EV68 infects both adults and children. However, the molecular basis of EV68 pathogenesis is unknown. Here we report that EV68 inhibits Toll-like receptor 3 (TLR3)-mediated innate immune responses by targeting the TIR domain-containing adaptor inducing beta interferon (TRIF). In infected HeLa cells, EV68 inhibits poly(I center dot C)-induced interferon regulatory factor 3 (IRF3) activation and beta interferon (IFN-beta) expression. Further investigations revealed that TRIF, a critical adaptor downstream of TLR3, is targeted by EV68. When expressed alone, 3C(pro), an EV68-encoded protease, cleaves TRIF. 3Cpro mediates TRIF cleavage at Q312 and Q653, which are sites in the amino-and carboxyl-terminal domains, respectively. This cleavage relies on 3C(pro)'s cysteine protease activity. Cleavage of TRIF abolishes the capacity of TRIF to activate NF-kappa B and IFN-beta signaling. These results suggest that control of TRIF by 3C(pro) may be a mechanism by which EV68 subverts host innate immune responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available